Medically reviewed by a licensed healthcare professional. Last updated May 2026.
Key Takeaways
- Skip the dose if you have been vomiting more than 24 hours, cannot keep fluids down, or show signs of dehydration. Continue the dose if your illness is mild and you are eating normally.
- One missed weekly dose usually does not require restarting. After 2+ missed semaglutide doses, the label allows either resuming or re-titrating, so ask your prescriber. Tirzepatide has a 4-day missed-dose window and no clean 2-week label rule.
- Severe upper abdominal pain that radiates to the back is the one symptom you treat as pancreatitis until a lipase test says otherwise. Do not take the next dose. Get evaluated.
- GLP-1s slow gastric emptying and can reduce overall intake, so dehydration on a sick day can sneak up faster than expected. Aim for 64 ounces of fluids on a schedule, not when you feel thirsty.
- Most prescribers do not proactively cover any of this. You have to bring it up at your next visit if you want a written sick-day plan.
The question I get most from new GLP-1 patients is not about side effects. It is about what to do when they actually get sick. A stomach bug, food poisoning, a bad cold that knocks out their appetite, a 24-hour flu that has them throwing up. The prescriber never covered it. The pharmacist never covered it. The dose schedule on the back of the pen does not mention it. And the answer matters, because a small fraction of patients who dose through a stomach virus end up in the ER for dehydration the medication may have made harder to recover from.
Here is the rough mental model I use when patients ask. Your GLP-1 is doing two things every day, sick or not. It slows your gastric emptying, and it suppresses your hunger. Both are useful when you are healthy and trying to lose weight. Both can reduce overall intake enough that you fall behind on fluids without noticing, which matters more when you are nauseous, vomiting, and trying to rehydrate. The right move on a sick day is to recognize that the medication is now amplifying the illness instead of helping you, and to hold the next dose until you are eating and drinking like yourself again.
When to skip the dose
The clear-yes cases:
- You have been vomiting more than 24 hours. Any cause. Stomach virus, food poisoning, migraine-related, whatever. If you are still vomiting 24 hours in, the GLP-1 is making it harder to recover, not easier.
- You cannot keep clear fluids down. Water, electrolyte drink, broth. If you sip and it comes back up within an hour, skip the dose.
- You are visibly dehydrated. Dark urine, dry mouth, dizziness on standing, infrequent urination, or a faster-than-normal heartbeat at rest are the bedside markers most patients recognize.
- Your appetite is gone for more than 48 hours from anything other than the GLP-1 itself. A bad cold can do this. So can a fever. Either way, the medication is now compounding undernourishment rather than treating obesity.
The clear-no cases:
- A mild cold with normal eating. You feel crummy but you are still eating dinner. Take the dose.
- A headache or seasonal allergies. Not GI-relevant. Take the dose.
- A few hours of mild queasiness that resolves. Take the dose at the usual time.
The middle cases (use judgment, lean toward skipping):
- You ate something off and feel off but have not vomited. Watch for four to six hours. If you start vomiting, skip. If you stabilize, dose normally.
- You have low-grade fever with mild GI symptoms. If you are eating crackers and drinking fluids without trouble, dose. If you are pushing food away, skip.
How long can you skip before it matters
For the weekly GLP-1s, the medication has a long half-life (about a week for semaglutide, about five days for tirzepatide). Translation: one missed dose still has plenty of medication in your bloodstream from the prior week. You will not lose the appetite suppression in 24 to 72 hours. You probably will not even notice the difference.
The tolerance question is a longer arc. What happens pharmacologically:
| Gap from last dose | What happens |
|---|---|
| 1 dose missed (1 week) | Medication still active. Minimal change in appetite. |
| 2 weeks | Medication mostly cleared. Appetite starting to return. |
| 3 weeks | Effectively reset. Hunger fully back. |
| 4+ weeks | Full restart pattern. |
What the official labels actually tell you to do varies by medication.
Wegovy and Ozempic (semaglutide): if the next scheduled dose is more than 2 days away, take the missed dose as soon as you remember. If less than 2 days, skip and resume on the regular day. After 2 or more consecutive missed doses, the label gives prescribers a choice: have you resume your usual dose at the next scheduled day, OR have you reinitiate the dose escalation schedule to minimize GI side effects from rebound. Which path your prescriber picks depends on how you tolerated the medication originally.
Zepbound and Mounjaro (tirzepatide): the label window is 4 days. Take a missed dose as soon as possible within 4 days; after that, skip it and resume on the regularly scheduled day. The tirzepatide label does not specify a 2-week rule, so anything beyond one or two missed doses is a conversation with your prescriber rather than a label-mandated step.
In practice, regardless of which medication you are on, most prescribers will have you step back one dose level after a 3+ week gap to manage rebound nausea before stepping back up. That is clinical convention, not a hard label rule.
For daily GLP-1s (Saxenda, Victoza), the same logic applies but compressed. Missing a single day is invisible. Missing more than three or four days starts to feel like a partial restart.
The one thing patients confuse with stomach flu
There is exactly one GLP-1 complication that gets confused with a stomach virus often enough to be worth knowing about: acute pancreatitis. It is rare. Background population rates run about 0.1 to 0.3 percent per year for GLP-1 patients, which is small but not zero. The reason it matters is that the early symptoms overlap with stomach flu, which is the kind of overlap that gets missed.
What pancreatitis actually feels like, in patient terms:
- The pain is upper abdominal, in the area roughly between your bottom ribs.
- It radiates to the back, like someone is pressing on your spine from the inside.
- It is severe and persistent. Not wave-like, not better when you change position, not relieved by burping or vomiting.
- Nausea and vomiting often come with it, but the pain is the dominant symptom. Patients say it feels qualitatively different from any nausea they had earlier in their GLP-1 treatment.
- It can include a low-grade fever but does not have to.
What it does NOT feel like:
- Run-of-the-mill GLP-1 nausea that improves after the first month.
- Stomach cramps that come and go.
- Vomiting that resolves after each episode.
- Pain in the lower abdomen.
If the pain matches the pancreatitis pattern, the rule is: do not take the next dose, and get evaluated. Lipase three times the upper limit of normal is one of the diagnostic criteria for acute pancreatitis; the full clinical picture combines symptoms, enzymes, and imaging. It is a fast workup. The downside of being wrong is one ER visit. The downside of missing it is an admission.
After you skip, when to actually resume
The general rule: resume your normal dose at the next scheduled day, as long as:
- You have been eating something resembling your normal pattern for at least 24 hours.
- You are not still vomiting or having severe nausea.
- You are not actively dehydrated.
If those conditions are met, restart at the usual dose. If they are not yet met, wait another day. If you are still not eating after three or four days, that is a phone call to your prescriber, not a wait-and-see.
What to do if you are in the ER
If you do end up in the ER, the hand-off is simple but important. Tell the triage nurse:
- The exact medication name and dose. Not "I am on a GLP-1." Say "I am on tirzepatide 7.5 mg weekly, last injection was Tuesday."
- When your last dose was. Because the half-life is roughly a week, a tirzepatide dose three days before an ER visit is still active in your bloodstream and affects how the team should think about hydration, anti-emetics, and any imaging.
- What your normal GLP-1 side effects feel like. This helps the ER team calibrate whether your current symptoms are the medication or something else. Patients who can say "this nausea is way worse than my usual" give the team a better starting point than "I have nausea."
For more on identifying serious side effects versus normal adjustment, see our GLP-1 side effects timeline and our nausea management guide. For finding a clinic that will write you a clear sick-day plan and adjust dose when needed, our 90-second matching quiz is the fastest path.
The honest version of this conversation
Most GLP-1 prescribers are not proactively covering sick-day rules because the medications are still new enough that the protocols are not formalized in any one place. The diabetes world has sick-day rules going back decades. The obesity-medicine world is just now catching up. Until that happens at your prescriber's office, you have to ask. At your next visit, say two sentences: "What is my sick-day plan if I cannot keep food down for a day or two, and what is the threshold for going to the ER instead of waiting it out?" Most clinicians will give you a clear answer. If they cannot, that tells you something useful about who is actually prescribing for you.
Sources
- Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with GLP-1 Receptor Agonists, Multidisciplinary Expert Consensus (PMC)
- Pancreatitis Risk Associated with GLP-1 Receptor Agonists, PMC
- Cleveland Clinic ConsultQD, Reconciling GLP-1s and Pancreatitis
- Wegovy Prescribing Information (Novo Nordisk)
- Ozempic Prescribing Information (Novo Nordisk)
- Zepbound Prescribing Information (Eli Lilly)
